Dr. Syed Jawad Ali Shah has obtained his PhD degree from School of Pharmacy, Lanzhou University, China where he worked extensively on structural computational chemistry of intrinsically disordered protein Tau and its mutations and post-translational modifications implicated in neurodegenerative diseases. He has spent about ten years in research and development with primary focus on early drug discovery and development using computational chemistry and wet-lab approaches. Recently he has been awarded access to scientific computing under “Red Española de Supercomputación (RES)”, Spain and has been granted research visit grant by HPC-Europa3 to carry out research project in Barcelona Super Computing (BSC) Center. Previously, he has been invited as junior researcher at Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany where he received training in MD simulations and hybrid QMMM calculations to investigates the ATP hydrolysis in actin-myosin motors. He also received research training from Pharmazentrum Bonn and BIT-LIMES institutes of University of Bonn, Germany funded by DAAD, Germany where he received training in radio-ligand binding assays and β-arrestin assays for the identification of novel adenosine and GPCRs modulators as well as their computational studies.